HAVEN-Connect Youth Suicide Prevention Program
This study is testing a program called HAVEN-Connect, which aims to prevent depression and suicide in Black youth aged 13-19. It combines the Youth-Connect program for young people with Connect training for adults, focusing on building strong support networks. The program will be introduced in churches that are primarily Black or African American and where most members speak English. Researchers want to see if HAVEN-Connect can reduce symptoms of depression and lower the risk of suicide in participants. They will also look at how the program might improve connections with peers and adults, self-regulation skills, and the use of mental health services.
- Study design
- This study will involve 240 adolescents from 12 churches. Churches will be randomly assigned to either receive the HAVEN program immediately or be placed on a waitlist.
- What's involved
- You would complete questionnaires at the start of the study, and then again at 1 month and 6 months after the program begins.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 6 months after the program starts.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
HAVEN-Connect Youth Suicide Prevention
At a glance
Conditions
NCT07401940
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Mt. Sinai Hospital; Ichon School of Medicine
New York, New Yorkstudy coordinator listed
Recruiting
University of Rochester Medical Center
Rochester, New Yorkstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Sherry D Molock, Ph.D., M.Div. · PRINCIPAL_INVESTIGATOR · George Washington University, Dept of Psychological & Brain Sciences
- Sidney Hankerson, MD, MBA · PRINCIPAL_INVESTIGATOR · Mt. Sinai Icheon School of Medicine - Psychiatry
- Peter Wyman, Ph.D. · PRINCIPAL_INVESTIGATOR · University of Rochester Medical Center - Psychiatry
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Kiddie-Computerized Adaptive Testing for Mental Disordersbaseline, 1- and 6-month followup
Measures depressive symptoms and suicide risk; it asks fewer questions than traditional suicide screeners because it is response adaptive. Instead of fixing the items and allowing the precision of measurement to vary, the authors fix the precision of measurement and allow the items to vary. The K-CAT adaptively selects a small set of items from a large item-bank of 2,120 items, using a 4-point Likert scale (Strongly Agree, Agree, Disagree, Strongly Disagree). The results yield four metrics: 1) a severity score ranging from 0 - 100, with 0 representing the lowest severity, and 100 representing the highest severity. The prompt for each question is: "In the past two weeks..." Sample items include: "I felt worthless" I felt everyone would be better off without me" .